Introduction {#sec1-1}
============

Hepatocellular carcinoma (HCC) is a common malignancy, and its prevalence is increasing in developing countries.\[[@ref1]\] HCC is the third most common cause of cancer-related deaths complicating liver cirrhosis in most cases.\[[@ref2]\]

In Egypt, there was a remarkable increase in the proportion of HCC among patients with chronic liver diseases. This increasing incidence may be explained by the increasing risk factors including the emergence of hepatitis C virus (HCV) over the equal time frame, the contribution of hepatitis B virus (HBV) infection, improvement of the screening programs and diagnostic tools for liver cancer as well as the improved survival rates among patients with cirrhosis to allow time for some of them to develop HCC.\[[@ref3]\]

HCC is complex in pathogenesis, which has been contemplated as diverse biologic characteristics in distinct populations.\[[@ref4]\]

HBV is considered as one of the major risk factors responsible for the development of liver cirrhosis and HCC. Previous data suggest that the HBx protein may additionally have an important role in HCC pathogenesis through inactivation of tumor suppressor gene (p53) contributing to the development of HCC.\[[@ref5]\]

Chronic HCV infection is a major risk factor for the development of HCC. Egypt has shown increasing importance for HCV infection in the etiology of liver cancer and the declining influence of HBV risk factors of HCC and HBV/HCV infection (25% and 15%, respectively).\[[@ref6]\]

Some studies linked HCC to diabetes mellitus (DM) and/or obesity, and as the blend of risk factors differs in different parts of the world, we design this retrospective study to clarify the epidemiology of HCC in Nile delta, Egypt and its relation to age, sex, residence, smoking, occupation, and viral hepatitis.

Methods {#sec1-2}
=======

HCC management unit in Tropical Medicine Department in Tanta University Hospital had their data registered and took consent from patients to use it for scientific research. The patient\'s files from January 2005 to January 2015 were reviewed.

The diagnosis of HCC was based on detection of hepatic focal lesion by one dynamic imaging techniques (dynamic computed tomography, dynamic magnetic resonance imaging) typical for HCC or alpha-fetoprotein \>200 if the hepatic focal lesion above 2 cm in cirrhotic liver or two dynamic imaging techniques typical for HCC if hepatic focal lesion 1--2 cm in cirrhotic liver. Otherwise, diagnosis of HCC depended on detection of hepatic focal lesion and alpha-fetoprotein \>400.

This retrospective study included the data of HCC patients who met these criteria, with special stress on their age, sex, residential history, for example, urban or rural type of residence, occupational history, for example, exposure to farming, smoking, presence of previous bilharzial infection (or history of antibilharzial treatment), their clinical and laboratory data including liver function tests and serum alpha-fetoprotein.

The data of radiological investigations, for example, abdominal ultrasonography: with stress on the following data: the liver: regarding the size, texture, border, reflectivity, homogeneity, periportal thickening, and hepatic veins. Focal lesions were reported regarding their number, site, size, shape, echogenicity, halo sign and neovascularization by color Doppler assessment, portal vein regarding its diameter, patency, direction of flow, respiratory variation, and velocity by color Doppler assessment. The spleen also was assessed regarding its size, splenic vein diameter, and the presence of collaterals. The presence of ascites and internal echoes and the presence of any lymph nodes and extrahepatic spread were also documented.

The data of abdominal triphasic computed tomography were reported with stress on the following data: presence of cirrhosis, splenomegaly, portal vein patency, ascites, focal lesion (number, site, size, shape, arterial enhancement), and portal vein diameter and patency.

Results {#sec1-3}
=======

One thousand four hundred and forty patients with HCC were diagnosed or referred to liver cancer clinic and liver cancer early detection clinic in Tropical Medicine Department in Tanta University Hospital from January 2005 to January 2015. Their mean age was 56.13 ± 9.53 years. They were 1123 (78%) males and 317 (22%) females. About 85.6% of our patient had their residence in rural areas. Among our 1440 HCC patients, 26.1% were diabetics, 44.86% were smokers, 37.8% of patients were Child\'s A, 35.3% were Child\'s B and 26.9% were Child\'s C. The demographic and clinical data of all studied patients are shown in [Table 1](#T1){ref-type="table"} and the laboratory data of the studied patients is shown in [Table 2](#T2){ref-type="table"}.
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Demographic and clinical data of all studied patients (*n*=1440)
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Laboratory data of hepatocellular carcinoma patients
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As regards number of the lesions, single lesion was detected in 47.5% of patients versus 52.5% had multiple lesions. While regarding the size of the tumor, 42.29% of patients had tumor size below 3 cm, in 12.77%, the size of tumor was 3--5 cm, while 44.93% of patients presented with tumor size above 5 cm. Nearly, 7.5% of HCC patients had portal vein thrombosis. The characters of focal lesions are shown in [Table 3](#T3){ref-type="table"}.
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Characters of focal lesions
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Concerning the etiology of HCC, HBV surface antigen (HBsAg)-positive patients were only 3.26%, while the majority of patients were HCV-Ab positive (94.86% of patients). Therefore, HCV was the predominant cause of HCC.

Discussion {#sec1-4}
==========

This retrospective study reviewed the files of HCC patients over the last decade. In the current study, HCC was much higher in males. This was in agreement with Di Bisceglie\[[@ref7]\] who reported that men are two to three times higher than women in most regions. Higher prevalence of HCC in males may be explained by the higher susceptibility of males to environmental carcinogens and greater exposure to environmental risk factors, for example, pesticides and aflatoxin.\[[@ref8]\]

Kew\[[@ref4]\] reported male to female ratio of 3.7:1 in HCC patients, especially in population at high risk.

Our HCC patients had a mean age of 56.13 ± 9.53 years. This was much lower than Ryder\[[@ref8]\] who reported that the average age of HCC was 66 years and the seventh or eighth decades of life, respectively. However, Kew\[[@ref4]\] stated that the incidence of HCC increases progressively with advancing age, but in areas, with high risk, the mean age is definitely younger.

In this study, 85.56% of HCC cases were from rural areas. These results agree with that of el-Zayadi *et al*.\[[@ref3]\] who stated that most of HCC cases (75.2%) resided in rural areas. This may be due to more exposure to environmental carcinogens, for example, pesticides and exposure to aflatoxin in contaminated foods, for example, corn. Aflatoxin may induce the characteristic mutation in p53 preparing the way for HCV to cause liver cancer.\[[@ref9]\]

Concerning smoking, our study showed that 46.04% of HCC cases had a history of smoking and about half of them were heavy smokers; a nearly similar result was reported by Mohamed *et al*.,\[[@ref10]\] who reported that 49.6% of HCC cases had a history of smoking. Smoking may cause DNA damage and abnormal cell proliferation.

Nearly, one-quarter of our patients had DM. Davila *et al*., 2005\[[@ref11]\] stated that diabetes may be associated with a 2--3-fold increase in the risk of HCC, regardless of the presence of other major HCC risk factors.

As Nile delta has the highest prevalence of HCV in Egypt, according to demographic study performed in 2008, it may be among the areas of higher risk to HCC. In our study, 94.9% of cases were HCV positive; this was higher than that reported in Egyptian study by Mohamed *et al*.\[[@ref10]\] who reported 64.4% of HCC cases were positive and near to results by el-Zayadi *et al*.\[[@ref3]\] who reported 87.9% of HCC cases were positive. Our results go in agreement with Michielsen *et al*.\[[@ref12]\] who stated that in areas with an intermediate rate of liver tumors such as Southern Europe, Egypt, and Japan, HCV is the predominant cause of HCC. HCC was mostly discovered in patients with long-standing cirrhosis due to HCV.

Although HBV is considered worldwide as a major risk factor for liver cirrhosis and HCC, only 3.26% of HCC patients in our study had HBs-antigen seropositivity. Hence, in Nile delta, hepatitis C rather than hepatitis B was linked to the development of HCC in our region which may be related to the high prevalence of HCV in this area. This decrease of HBsAg positivity may be partially attributed to successful control measures of blood transfusion and vaccination and partially to the development of mutant or occult HBV infection, which requires costly assays for diagnosis.\[[@ref3][@ref13][@ref14]\]

Conclusions {#sec1-5}
===========

As in many developing countries, Egypt is undergoing an epidemiologic transition. With increasing environmental risk factors, increasing smoking rates, in addition to the significantly high HCV epidemiology, it is likely that HCC will continue to rise within the next few years. This study could help policymakers to create efficient prevention programs. In the era of new anti-HCV drugs, we hope that this will stop the rising trend of HCC.
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